Christine Follet-Veyrat
Sanofi R&D
Paris, France
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Novel Drug-Disease Modeling Framework for Oncology Benefit-Risk Evaluation: Application to Tusamitamab Ravtansine.
Journal: CPT: pharmacometrics & systems pharmacology
Published: July 11, 2025
Isatuximab-dexamethasone-pomalidomide combination effects on serum M protein and PFS in myeloma: Development of a joint model using phase I/II data.
Journal: CPT: pharmacometrics & systems pharmacology
Published: January 31, 2024
Joint modeling of tumor dynamics and progression-free survival in advanced breast cancer: Leveraging data from amcenestrant early phase I-II trials.
Journal: CPT: pharmacometrics & systems pharmacology
Published: September 21, 2023
Model-based simulation to support the approval of isatuximab alone or with dexamethasone for the treatment of relapsed/refractory multiple myeloma in Japanese patients.
Journal: CPT: pharmacometrics & systems pharmacology
Published: September 30, 2022
Exposure-response analyses for selection/confirmation of optimal isatuximab dosing regimen in combination with pomalidomide/dexamethasone treatment in patients with multiple myeloma.
Journal: CPT: pharmacometrics & systems pharmacology
Published: November 24, 2021
Joint modelling and simulation of M-protein dynamics and progression-free survival for alternative isatuximab dosing with pomalidomide/dexamethasone.
Journal: British journal of clinical pharmacology
Published: July 21, 2021
PK/PD modeling analysis for dosing regimen selection of isatuximab as single agent and in combination therapy in patients with multiple myeloma.
Journal: CPT: pharmacometrics & systems pharmacology
Published: February 12, 2021
Accelerating diagnosis of Parkinson's disease through risk prediction.
Journal: BMC neurology
Published: August 22, 2020
Bayesian Individual Dynamic Predictions with Uncertainty of Longitudinal Biomarkers and Risks of Survival Events in a Joint Modelling Framework: a Comparison Between Stan, Monolix, and NONMEM.
Journal: The AAPS journal
Published: August 26, 2019
Nonlinear joint models for individual dynamic prediction of risk of death using Hamiltonian Monte Carlo: application to metastatic prostate cancer.
Journal: BMC medical research methodology
Published: February 08, 2017
Translational Model-Based Strategy to Guide the Choice of Clinical Doses for Antibody-Drug Conjugates.
Journal: Journal of clinical pharmacology
Published: September 26, 2016
International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents.
Journal: Cancer chemotherapy and pharmacology
Published: October 20, 2015
Last Updated: 09/26/2026